Ascelia Pharma AB: eps_diluted
| Value | {"amount": -1.48, "concept": "ifrs-full:DilutedEarningsLossPerShare"} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | Ascelia Pharma AB |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-23T23:08:51.954826+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/a23e732a-ec9f-44a6-a385-a8d766f2cc25
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:5493002YR9VCJJPWYN08:2024-12-31Retrieved: 2026-08-23T23:08:51.954826+02:00
Raw response sha256:
3618fd33ae161b1e5e0c96fd474d2620…Cite as: FACTANKER, https://factanker.com/fact/a23e732a-ec9f-44a6-a385-a8d766f2cc25
History
- no predecessors — first report